Bristol-Myers Squibb - Company & Market Research Reports

Home /
Companies /
Bristol-Myers Squibb

Bristol-Myers Squibb is a pharmaceutical company that develops products for various diseases, such as oncology, virology, cardiovascular diseases, serious mental illness, and immunoscience. The company has delivered 12 new medicines to patients in the past 7 years. It also provides products for Alzheimer's disease, atherosclerosis/thrombosis, hepatitis, HIV/AIDS, solid organ transplant rejection, and a wide variety of other diseases and disorders. Bristol-Myers Squibb was founded in 1990 and is based in Uxbridge, United Kingdom.

REFINE BY

KEYWORD

CATEGORIES

Oncology Drugs 480
Immune Disorders Drugs 201
Drug Discovery 169
Cardiovascular Drugs 159
Infectious Diseases Drugs 138
Biopharmaceuticals 133
Clinical Trials 126
Endocrine and Metabolic Disorders Drugs 110
Central Nervous System Drugs 100
Pharmaceuticals 95
Musculoskeletal Disorders Drugs 94
Leukemia Drugs 84
Hematological Drugs 83
Liver and Kidney Disorders Drugs 81
Lymphoma Drugs 62
Dermatological Drugs 55
Diabetes Drugs 54
Skin Cancer Drugs 51
Brain Cancer Drugs 45
Respiratory Drugs 44
Gastrointestinal Drugs 41
Mental Disorders Drugs 41
Lung Cancer Drugs 39
Pharmaceutical Intermediates 38
Drug Delivery 37
Immunosuppressive Drugs 34
Pharmaceutical Manufacturing 33
Infusions and Injectables 30
Liver Cancer Drugs 28
Bladder Cancer Drugs 25
Analgesics 25
Drugs by Therapeutic Area 24
Antibiotics 23
Kidney Cancer Drugs 22
Colon Cancer Drugs 20
HIV/AIDS Drugs 20
Prostate Cancer Drugs 18
Pancreatic Cancer Drugs 18
Schizophrenia Drugs 18
Urological Disorders Drugs 17
Sexual and Reproductive Health Drugs 15
Ovarian Cancer Drugs 14
Cervical Cancer Drugs 14
Breast Cancer Drugs 13
Cancer Vaccines 13
Thyroid Cancer Drugs 12
Psoriasis Drugs 12
Generic Drugs 10
Biosimilars and Biosuperiors 10
Over the Counter (OTC) Drugs 9
Vaccines 9
Transdermal and Transmucosal Drug Delivery 8
Anti-Obesity Drugs 8
Optical Disorders Drugs 7
Alzheimer's Disease Drugs 7
Uterine Cancer Drugs 6
Company Reports 5
Anxiety Drugs 4
Pharmacoeconomics 3
Cough and Cold Drugs 3
Vitamins and Dietary Supplements 3
Addiction Disorders Drugs 2
Animal Pharmaceuticals 2
Asthma Drugs 2
Inhalers and Nebulisers 1
Anesthetic Drugs 1
Allergy Drugs 1
Bronchitis Drugs 1

SHOW ALL

REPORT TYPE

All Reports

Company Reports

Market Reports

Google Reviews

4.8



276 reviews

2,461 Results (Page 63 of 124)
- Relevance
  Sort by

Myelodysplastic Syndrome Global Market Report 2024

 Report
January 2024
175 Pages
Global

From

€4937EUR$5,000USD£4,123GBP

Leukemia Therapeutics Global Market Report 2024

 Report
January 2024
200 Pages
Global

From

€4937EUR$5,000USD£4,123GBP

Cutaneous T-Cell Lymphoma - Market Insight, Epidemiology and Market Forecast - 2034

 Report
March 2024
210 Pages
Global

From

€5495EUR$5,565USD£4,589GBP

€7850EUR$7,950USD£6,555GBP

Rare Disease Treatment Market Report and Forecast 2023-2031

 Report
April 2023
147 Pages
Global

From

€5924EUR$5,999USD£4,947GBP

Sinusitis Treatment Market - Global Industry Analysis, Size, Share, Growth, Trends, and Forecast 2023-2030 - By Product, Technology, Grade, Application, End-user and Region (North America, Europe, Asia Pacific, Latin America and Middle East and Africa)

 Report
July 2023
220 Pages
Global

€4537EUR$4,595USD£3,789GBP

NEED HELP FINDING THE RIGHT PRODUCT? Farid will help you find what you are looking for.

Call: 1-800-526-8630 ASK A QUESTION REQUEST A CALL BACK

Glucagon-like Peptide 1 Global Market Report 2024

 Report
January 2024
200 Pages
Global

From

€3950EUR$4,000USD£3,298GBP

Multiple Myeloma Market By Drug Type (Chemotherapy, Protease Inhibitors, Monoclonal Antibody, Others), By Disease Type (Active Multiple Myeloma, Smoldering Multiple Myeloma), By End User (Hospitals, Clinics, Others): Global Opportunity Analysis and Industry Forecast, 2021-2031

 Report
March 2023
411 Pages
Global

From

€3525EUR$3,570USD£2,944GBP

Hypopharyngeal Cancer Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players, 2022 Update

 Report
May 2022
168 Pages
Global

From

€1975EUR$2,000USD£1,649GBP

Nasopharyngeal Cancer Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players, 2022 Update

 Report
April 2022
342 Pages
Global

From

€2469EUR$2,500USD£2,061GBP

Anal Cancer Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players, 2022 Update

 Report
April 2022
216 Pages
Global

From

€1975EUR$2,000USD£1,649GBP

Osteosarcoma Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players, 2022 Update

 Report
April 2022
316 Pages
Global

From

€2469EUR$2,500USD£2,061GBP

Multiple Myeloma Market Insight, Epidemiology and Market Forecast - 2034

 Report
April 2024
566 Pages
Global

From

€5495EUR$5,565USD£4,589GBP

€7850EUR$7,950USD£6,555GBP

Novel T-Cell Immunotherapies Market: Focus on T-Cells, Tregs, Activated T-Cells, Virus-driven T-Cells & T-Cell Vaccines - Distribution by Type of T-Cell Therapy, Target Indications , Key Players and Key Geographies: Industry Trends and Global Forecasts, 2021-2030

 Report
June 2021
193 Pages
Global

From

€4739EUR$4,799USD£3,957GBP

Breast Cancer Treatment Market Report and Forecast 2023-2031

 Report
April 2023
147 Pages
Global

From

€5924EUR$5,999USD£4,947GBP

Leukemia Therapeutics Market by Type, Drug Class, Distribution Channel: Global Opportunity Analysis and Industry Forecast, 2021-2031

 Report
February 2023
392 Pages
Global

From

€3525EUR$3,570USD£2,944GBP

Antipsychotic Drugs Global Market Insights 2024, Analysis and Forecast to 2029, by Market Participants, Regions, Technology, Product Type

 Report
January 2024
90 Pages
Global

From

€3500EUR$3,797USD£3,025GBP

Diffuse Large B-Cell Lymphoma - Pipeline Insight, 2024

 Clinical Trials
June 2024
240 Pages
Global

From

€2074EUR$2,100USD£1,732GBP

€2962EUR$3,000USD£2,474GBP

B-Cell Non-Hodgkin Lymphoma - Market Insight, Epidemiology and Market Forecast - 2034

 Report
June 2024
200 Pages
Global

From

€5495EUR$5,565USD£4,589GBP

€7850EUR$7,950USD£6,555GBP

Follicular Lymphoma - Market Insight, Epidemiology and Market Forecast - 2034

 Report
June 2024
200 Pages
Global

From

€5495EUR$5,565USD£4,589GBP

€7850EUR$7,950USD£6,555GBP

Waldenstrom's Macroglobulinemia (WM) Treatment Market - Growth, Trends, Covid-19 Impact, and Forecasts (2023 - 2028)

 Report
January 2023
110 Pages
Global

From

€4690EUR$4,750USD£3,917GBP

2,461 Results (Page 63 of 124)
- 1
- 61
- 62
- 63
- 64
- 65

ASK A QUESTION

An error occurred while sending the message. Should this issue persist, email us at help@researchandmarkets.net

*Required Information

Name*

Email Address* Please provide your business or academic email address.

Country*

Phone Number*

Your Question*

I have read Research and Markets' Privacy Policy and consent to the processing of my personal data.

We request your telephone number so we can contact you in the event we have difficulty reaching you via email. We aim to respond to all questions on the same business day.